Healthcare -
Biotechnology - NASDAQ - US
$ 11.2
1.08 %
$ 454 M
Market Cap
-2.24
P/E
KROS - GROSS PROFIT
Gross Profit KROS - Keros Therapeutics, Inc.
-664 K
LAST VALUE
-1.71%
2 YEAR CAGR
-43.01%
5 YEAR CAGR
0.00%
10 YEAR CAGR